# PharmExec

> PharmExec - Healthcare Publication

- Base URL: https://www.pharmexec.com
- Generated: 2026-08-08T01:47:23.943Z
- Content updates: multiple times daily

## Content Access for AI Agents

This site supports content negotiation for AI/LLM consumption. Request any article URL with an appropriate Accept header to receive structured content instead of HTML.

**Supported content types:**
- `text/markdown` — Clean Markdown with YAML frontmatter
- `text/plain` — Plain text (same as Markdown)
- `text/html` — Default HTML response

**Example request:**
```
curl -H "Accept: text/markdown" https://www.pharmexec.com/view/article-slug
```

**YAML frontmatter schema** (returned with every Markdown response):

| Field | Type | Description |
|-------|------|-------------|
| `title` | string | Article headline |
| `description` | string | Summary/excerpt (max 300 chars) |
| `url` | string | Canonical article URL |
| `canonical_url` | string | Canonical URL if different from `url` |
| `published` | ISO 8601 | Original publication date |
| `modified` | ISO 8601 | Last modification date |
| `authors` | string[] | Author display names |
| `content_type` | string | Content category (e.g., "News", "Clinical") |
| `categories` | string[] | Taxonomy categories |
| `tags` | string[] | SEO tags |
| `image` | string | Featured image URL |
| `publisher` | string | Publication/site name |

**Discovery headers** (included on all responses):
- `Link: <https://www.pharmexec.com/llms.txt>; rel="llms"` — RFC 8288 link to this file
- `X-Llms-Txt: https://www.pharmexec.com/llms.txt` — Explicit discovery header

## Usage Policy

- Robots policy: [https://www.pharmexec.com/robots.txt](https://www.pharmexec.com/robots.txt)
- Cache behavior: responses are cached for ~5 minutes (max-age=300, stale-while-revalidate=329)
- Rate guidance: prefer RSS and sitemap feeds over crawling individual pages
- Attribution: All content © MJH Life Sciences. Include source URLs when citing.

## Content Categories

- [Content Engagement Hubs](https://www.pharmexec.com/content-engagement-hubs)
- [Country Reports](https://www.pharmexec.com//topic/country-reports)
- [Editorial Podcasts](https://www.pharmexec.com/editorial-podcasts)
- [Editorial Videos](https://www.pharmexec.com/editorial-videos)
- [Events](https://www.pharmexec.com/events)
- [Front & Center](https://www.pharmexec.com/front-center)
- [News](https://www.pharmexec.com/news)
- [Pharma Pulse](https://www.pharmexec.com/pharma-pulse)
- [Profiles in Medicine](https://www.pharmexec.com/profiles-in-medicine)
- [Sponsored Content](https://www.pharmexec.com/sponsored-content)
- [Sponsored Podcasts](https://www.pharmexec.com/sponsored-podcasts)
- [Sponsored Videos](https://www.pharmexec.com/sponsored-videos)
- [Topic](https://www.pharmexec.com/topic)
- [Video Series](https://www.pharmexec.com/video-series)
- [Webcasts](https://www.pharmexec.com/webcasts)
- [Whitepapers](https://www.pharmexec.com/whitepapers)

## Featured Content

- [Pharmaceutical Executive Daily: Amazon Pharmacy to Offer GLP-1 Delivery Service](https://www.pharmexec.com/view/daily-amazon-pharmacy-glp-1-delivery-service): In today's Pharmaceutical Executive Daily, Amazon Pharmacy launches a GLP-1 delivery service for eligible Medicare patients, Tarsus Pharmaceuticals ag...
- [Amazon Pharmacy Launches GLP-1 Delivery Service ](https://www.pharmexec.com/view/amazon-launches-glp-1-delivery-service): Amazon Pharmacy is now delivering GLP-1 weight management medications to eligible Medicare patients. 
- [Tarsus Pharmaceuticals to Acquire Alkeus Pharmaceuticals for $450 Million ](https://www.pharmexec.com/view/tarsus-pharmaceuticals-acquire-alkeus-): Tarsus Pharmaceuticals has agreed to acquire Alkeus Pharmaceuticals for $450 million, centering the deal on gildeuretinol. 
- [FDA Grants Accelerated Approval to Tudriqev in Combination with Nivoumab for Advanced Melanoma](https://www.pharmexec.com/view/fda-grants-accelerated-approval-tudriqev-combination-nivoumab-melanoma): FDA has granted accelerated approval to Replimune's Tudriqev  plus nivolumab for anti-PD-1-refractory unresectable advanced cutaneous melanoma. 
- [FDA's New Frontier: Drug Pricing Enters the Conversation](https://www.pharmexec.com/view/fda-s-new-frontier-drug-pricing-enters-the-conversation): Kirsten Axelsen, Julie Tierney, and Rachel Turow discuss what it takes to lead through a pricing environment that will never be the same — and what FD...
- [Onshoring Commitments and the Public Narrative Behind Them](https://www.pharmexec.com/view/onshoring-commitments-and-the-public-narrative-behind-them): Rachel Turow and Maggie Farley examine what's really at stake as companies commit to new U.S. manufacturing — from FDA inspection risk to how these an...
- [The Structural Problems Causing the Pharma and Biotech Industries’ Compliance Failures](https://www.pharmexec.com/view/structural-problems-causing-biotech-industries-compliance-failures): Krieger Scientific's Joseph Morwald explains how siloed departments, disconnected systems, and a lack of cross-functional accountability are creating...
- [The Merger Paradox: Why Transformational Mergers Create Extraordinary Value and Frequently Fail](https://www.pharmexec.com/view/merger-paradox-transformational-extraordinary-value-fail): The AstraZeneca-BMS rumors have reframed how the industry thinks about scale, capability, and competitive advantage.
- [Your Questions Answered: The Biggest Pharma Stories of the Week of August 3-7, 2026](https://www.pharmexec.com/view/questions-answered-biggest-stories-week-august-3-7-2026): From Lilly's blockbuster earnings to a first-of-its-kind narcolepsy approval, a new mRNA flu vaccine, and a potential mega-merger that would reshape t...
- [Pharmaceutical Executive Daily: FDA Approves Orezeyful](https://www.pharmexec.com/view/daily-fda-approves-orezeyful): In today's Pharmaceutical Executive Daily, an antitrust attorney weighs the legal risks of a hypothetical AstraZeneca-Bristol Myers Squibb merger, Eli...

## Feeds and Indexes

- [RSS Feed](https://www.pharmexec.com/rss.xml): Latest articles in XML syndication format
- [Sitemap](https://www.pharmexec.com/sitemap.xml): Complete URL index for all published pages
- [News Sitemap](https://www.pharmexec.com/sitemap-news.xml): Recent articles optimized for news indexing
- [Authors Directory](https://www.pharmexec.com/authors): Browse all contributors and their published work